Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy.[ Read More ]
The intrinsic value of one AVNS stock under the base case scenario is HIDDEN Compared to the current market price of 18.7 USD, Avanos Medical, Inc. is HIDDEN
Current Assets | 487 M |
Cash & Short-Term Investments | 87.7 M |
Receivables | 143 M |
Other Current Assets | 256 M |
Non-Current Assets | 1.21 B |
Long-Term Investments | 0 |
PP&E | 144 M |
Other Non-Current Assets | 1.06 B |
Current Liabilities | 235 M |
Accounts Payable | 56.3 M |
Short-Term Debt | 34.2 M |
Other Current Liabilities | 144 M |
Non-Current Liabilities | 222 M |
Long-Term Debt | 188 M |
Other Non-Current Liabilities | 33.8 M |
Revenue | 673 M |
Cost Of Revenue | 294 M |
Gross Profit | 380 M |
Operating Expenses | 376 M |
Operating Income | 4.2 M |
Other Expenses | 66 M |
Net Income | -61.8 M |
Net Income | -61.8 M |
Depreciation & Amortization | 46.1 M |
Capital Expenditures | -17.8 M |
Stock-Based Compensation | 15.8 M |
Change in Working Capital | -18 M |
Others | 3 M |
Free Cash Flow | 14.6 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
8 months ago
Mar 14, 2024
|
Sell 72.6 K USD
|
Greiner Michael
SVP - Chief Financial Officer |
- 3800
|
19.11 USD |
8 months ago
Mar 14, 2024
|
Sell 13.7 K USD
|
Greiner Michael
SVP - Chief Financial Officer |
- 714
|
19.12 USD |
8 months ago
Mar 14, 2024
|
Sell 42.7 K USD
|
Greiner Michael
SVP - Chief Financial Officer |
- 2231
|
19.13 USD |
8 months ago
Mar 14, 2024
|
Sell 6.45 K USD
|
Greiner Michael
SVP - Chief Financial Officer |
- 337
|
19.14 USD |
8 months ago
Mar 14, 2024
|
Sell 15.5 K USD
|
Greiner Michael
SVP - Chief Financial Officer |
- 808
|
19.15 USD |
8 months ago
Mar 14, 2024
|
Sell 2.11 K USD
|
Greiner Michael
SVP - Chief Financial Officer |
- 110
|
19.16 USD |
8 months ago
Mar 11, 2024
|
Bought 9.92 K USD
|
Shimer Julie Ann
Director |
+ 500
|
19.85 USD |
3 years ago
Sep 15, 2021
|
Bought 25.3 K USD
|
OLEARY PATRICK J
Director |
+ 800
|
31.67 USD |
3 years ago
Sep 15, 2021
|
Bought 28.5 K USD
|
OLEARY PATRICK J
Director |
+ 900
|
31.65 USD |
3 years ago
Sep 15, 2021
|
Bought 27 K USD
|
OLEARY PATRICK J
Director |
+ 853
|
31.62 USD |
3 years ago
Sep 15, 2021
|
Bought 77.3 K USD
|
OLEARY PATRICK J
Director |
+ 2447
|
31.61 USD |
4 years ago
May 08, 2020
|
Bought 142 K USD
|
BLACKFORD GARY
Director |
+ 5000
|
28.5 USD |
4 years ago
May 08, 2020
|
Bought 145 K USD
|
BLACKFORD GARY
Director |
+ 5000
|
29 USD |
5 years ago
May 30, 2019
|
Bought 140 K USD
|
Woody Joseph Fralin
Chief Executive Officer |
+ 3500
|
39.95 USD |
5 years ago
Nov 28, 2018
|
Bought 152 K USD
|
Woody Joseph Fralin
Chief Executive Officer |
+ 3500
|
43.35 USD |
5 years ago
Nov 27, 2018
|
Bought 87.5 K USD
|
Voskuil Steven E
SVP, Chief Financial Officer |
+ 2000
|
43.735 USD |
6 years ago
Nov 19, 2018
|
Bought 47.5 K USD
|
Wesley John W
SVP, General Counsel |
+ 1000
|
47.48 USD |
9 years ago
Sep 04, 2015
|
Bought 311 K USD
|
ABERNATHY ROBERT E
Chairman and CEO |
+ 10000
|
31.06 USD |
9 years ago
Sep 01, 2015
|
Bought 30 K USD
|
Voskuil Steven E
SVP, Chief Financial Officer |
+ 1000
|
30 USD |